Simon Goldman and David Grimm, who are responsible for managing investments for the UCL Technology Fund, the fund co-managed by UCLB and Albion Capital, have to [...]
About Lucy TuffinThis author has not yet filled in any details.
So far Lucy Tuffin has created 24 blog entries.
UCLB spinout Orchard Therapeutics has announced the pricing of its initial public offering in the United States of 14,285,715 American Depositary Shares (“ASDs” [...]
UCLTF investment manager David Grimm recently spoke to Global University Venturing editor Thierry Heles to explain more about how the Fund is investing in UCL t [...]
Data anonymisation software developer, Hazy gained coverage in The Telegraph’s Technology Intelligence pages, in light of the $1.8m it has raised in seed fundin [...]
Thursday the 5th July saw UCLB host its annual summer reception event, celebrating some of the remarkable achievements of the UCL spinout companies and ground-b [...]
Three UCL spin-out companies focused on delivering advanced therapeutics to treat a range of diseases received a substantial amount of investment following two [...]
BBC News technology reporter Dave Lee, discusses Niantic’s recent acquisition of UCL Computer Science spinout Matrix Mill. Niantic’s acquisition of Matrix Mill [...]
Matr, the online teaching platform, has announced it has closed a £4.75 million Series A investment round led by the UCL Technology Fund and Downing Ventures, w [...]
London, 19 June 2018 – Freeline Therapeutics Ltd (“Freeline”), a clinical stage company focused on treatment of chronic systemic diseases with liver targeted ad [...]
UCL TECHNOLOGY FUND HAS APPROVED INVESTMENT OF UP TO £1M IN THE DEVELOPMENT OF A GENE THERAPY FOR (PERFORIN DEFICIENT) FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSISLucy Tuffin2018-06-12T10:53:39+00:00
The UCL Technology Fund (UCLTF) has approved an investment of up to £1m to support Professor Bobby Gaspar’s development of a gene therapy for (perforin deficien [...]